Companies Chemed Corp
Chemed (CHE): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Chemed Corp’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO pay, last three years
- $12,625,106FY2023
- $12,769,564FY2024
- $12,904,720FY2025
CEO total pay was $12,904,720 in fiscal 2025, up from $12,769,564 in fiscal 2024.
FY2025: salary $1,858,792 · bonus $0 · stock awards $2,883,553 · option awards $5,036,021
Executives and directors
Frequently asked questions
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Kevin McNamara | $1,858,792 | $0 | $2,883,553 | $5,036,021 | $1,486,976 | $88,175 | $1,551,203 | $12,904,720 |
| President and CEO | ||||||||
| Nicholas Westfall | 648,040 | 0 | 0 | 0 | 0 | 0 | 3,646,822 | 4,294,862 |
| Former Executive Vice President | ||||||||
| Michael Witzeman | 600,400 | 0 | 743,973 | 1,672,551 | 408,835 | 0 | 288,983 | 3,714,742 |
| Executive Vice President, CFO and Controller | ||||||||
| Spencer Lee | 659,167 | 0 | 542,150 | 1,095,149 | 424,262 | 40,029 | 448,007 | 3,208,764 |
| Executive Vice President | ||||||||
| Joel Wherley | 579,055 | 519,921 | 411,559 | 1,500,026 | 0 | 39,428 | 0 | 3,049,989 |
| Vitas President and Chief Executive Officer | ||||||||
| Brian Judkins | 434,000 | 0 | 494,662 | 1,288,961 | 226,316 | 0 | 215,058 | 2,658,997 |
| Vice President, Secretary and Chief Legal Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Kevin McNamara | $12,904,720 | $12,769,564 | $12,625,106 | ↑ +135,156 |
| Nicholas Westfall | 4,294,862 | 5,139,747 | 4,709,954 | ↓ −844,885 |
| Michael Witzeman | 3,714,742 | 3,492,754 | 2,925,733 | ↑ +221,988 |
| Spencer Lee | 3,208,764 | 2,945,789 | 3,369,276 | ↑ +262,975 |
| Joel Wherley | 3,049,989 | — | — | — |
| Brian Judkins | 2,658,997 | 2,629,078 | — | ↑ +29,919 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The Company's executive compensation program is intended to align executives' interests with those of stockholders by rewarding long-term growth in the value of Capital Stock, paying for performance through cash and equity-based incentives, paying competitively to attract and retain senior executives, and creating incentives to maximize long-term business growth.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Compensation Strategies, Inc. |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | false |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Brian Judkins | RSU | 2025-02-14 | — | — | 375 | — | $208,991 |
| Kevin McNamara | RSU | 2025-02-14 | — | — | 2,186 | — | 1,218,280 |
| Kevin McNamara | OPTION | 2025-10-21 | — | — | 58,672 | — | 5,036,021 |
| Brian Judkins | OPTION | 2025-10-21 | — | — | 15,017 | — | 1,288,961 |
| Michael Witzeman | RSU | 2025-02-14 | — | — | 564 | — | 429,650 |
| Joel Wherley | RSU | 2025-02-14 | — | — | 312 | — | 237,678 |
| Joel Wherley | RSU | 2025-02-14 | — | — | 312 | — | 173,881 |
| Joel Wherley | OPTION | 2025-10-21 | — | — | 17,476 | — | 1,500,026 |
| Nicholas Westfall | RSU | 2025-02-14 | — | — | 632 | — | 352,220 |
| Kevin McNamara | RSU | 2025-02-14 | — | — | 2,186 | — | 1,665,273 |
| Michael Witzeman | RSU | 2025-02-14 | — | — | 564 | — | 314,323 |
| Michael Witzeman | OPTION | 2025-10-21 | — | — | 19,486 | — | 1,672,551 |
| Spencer Lee | RSU | 2025-02-14 | — | — | 411 | — | 313,096 |
| Spencer Lee | RSU | 2025-02-14 | — | — | 411 | — | 229,054 |
| Spencer Lee | OPTION | 2025-10-21 | — | — | 12,759 | — | 1,095,149 |
| Brian Judkins | RSU | 2025-02-14 | — | — | 375 | — | 285,671 |
| Nicholas Westfall | RSU | 2025-02-14 | — | — | 632 | — | 481,451 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Brian Judkins | $494,662 | $0 | $1,288,961 | 0.0% |
| Kevin McNamara | 2,883,553 | 0 | 5,036,021 | 0.0% |
| Michael Witzeman | 743,973 | 0 | 1,672,551 | 0.0% |
| Joel Wherley | 411,559 | 0 | 1,500,026 | 0.0% |
| Nicholas Westfall | 833,671 | 0 | 0 | 0.0% |
| Spencer Lee | 542,150 | 0 | 1,095,149 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Joel Wherley | RSU | 440 | — | $188,258 |
| Joel Wherley | RSU | 446 | — | 190,826 |
| Brian Judkins | RSU | 566 | — | 242,169 |
| Joel Wherley | RSU | 624 | — | 266,985 |
| Brian Judkins | RSU | 648 | — | 277,253 |
| Michael Witzeman | RSU | 666 | — | 284,955 |
| Spencer Lee | RSU | 742 | — | 317,472 |
| Brian Judkins | RSU | 750 | — | 320,895 |
| Spencer Lee | RSU | 804 | — | 343,999 |
| Spencer Lee | RSU | 822 | — | 351,701 |
| Michael Witzeman | RSU | 942 | — | 403,044 |
| Michael Witzeman | RSU | 1,128 | — | 482,626 |
| Joel Wherley | Option | 2,321 | 509.46 | — |
| Brian Judkins | Option | 3,222 | 509.46 | — |
| Spencer Lee | Option | 3,672 | 509.46 | — |
| Michael Witzeman | Option | 4,180 | 509.46 | — |
| Joel Wherley | Option | 5,588 | 597.7 | — |
| Spencer Lee | Option | 6,070 | 597.7 | — |
| Brian Judkins | Option | 6,882 | 597.7 | — |
| Michael Witzeman | Option | 8,930 | 597.7 | — |
| Spencer Lee | Option | 12,759 | 443.79 | — |
| Brian Judkins | Option | 15,017 | 443.79 | — |
| Joel Wherley | Option | 17,476 | 443.79 | — |
| Michael Witzeman | Option | 19,486 | 443.79 | — |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| George J. Walsh IIIIndependent · Board Chair · Nominating Committee | $274,000 | $166,394 | $0 | $0 | $54,633 | $495,027 |
| Patrick P. GraceIndependent · Audit Committee (Chair) · Nominating Committee (Chair) | 147,500 | 166,394 | 0 | 0 | 0 | 313,894 |
| Christopher J. HeaneyIndependent · Compensation Committee · Nominating Committee | 120,000 | 166,394 | 0 | 0 | 0 | 286,394 |
| John M. Mount JrIndependent · Audit Committee | 115,500 | 166,394 | 0 | 0 | 0 | 281,894 |
| Ron DeLyonsIndependent · Audit Committee | 115,500 | 166,394 | 0 | 0 | 0 | 281,894 |
| Eileen P. McCarthyIndependent · Compensation Committee | 109,000 | 166,394 | 0 | 0 | 0 | 275,394 |
| Andrea R. LindellIndependent · Compensation Committee | 109,000 | 166,394 | 0 | 0 | 0 | 275,394 |
| Thomas P. RiceNot independent · Departed during FY | 48,083 | 4,500 | 0 | 0 | 0 | 52,583 |
Board fee structure and ownership guideline
| Annual cash retainer | $80,000 |
|---|---|
| Annual equity retainer | $160,394 |
| Per board meeting fee | $3,000 |
| Committee chair fees (audit / comp / nom-gov) | 30,000 / 20,000 / 15,000 |
| Stock ownership guideline | $400,000 |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $1,038,583 |
| Equity awards (grant-date value) | $1,169,258 |
| All other compensation | $54,633 |
| Total cost of the board | $2,262,474 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Chemed as a peer
Companies that benchmark against CHE
18 companies name CHE as a compensation peer
The list of companies that name CHE as a peer is temporarily unavailable — recheck shortly.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Peer reciprocity
Of the companies Chemed Corp names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer’s own current proxy has been read — each mark is cited in the register to that peer’s filing. A dash means the peer’s current proxy was read and names no reciprocal group including Chemed Corp.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Pediatrix Medical Group | 2025 | Mark Ordan | $970,014 | $8,456,024 | $0 | $2,700,000 | $14,140,217 |
| 2 | The Ensign Group, Inc. | 2025 | Barry Port | 549,264 | 2,912,355 | 0 | 10,317,247 | 13,804,700 |
| 3 | Chemed Corp | 2025 | Kevin McNamara | 1,858,792 | 2,883,553 | 5,036,021 | 1,486,976 | 12,904,720 |
| 4 | Acadia Healthcare Co., Inc. | 2025 | Peter Scott | 534,091 | 10,336,831 | 0 | 1,984,500 | 12,855,422 |
| 5 | Addus Homecare Corp. | 2025 | R. Dirk Allison | 1,076,923 | 9,767,870 | 0 | 1,320,000 | 12,190,449 |
| 6 | RadNet, Inc. | 2025 | Howard Berger | 3,000,000 | 8,999,966 | 0 | 0 | 12,087,934 |
| 7 | Tetra Tech, Inc. | 2025 | Dan L. Batrack | 1,245,673 | 7,798,841 | 0 | 2,506,500 | 11,622,399 |
| 8 | AMN Healthcare Services, Inc. | 2025 | Cary Grace | 1,060,000 | 8,363,117 | 0 | 1,146,125 | 10,669,780 |
| 9 | Comfort Systems USA, Inc. | 2025 | Brian Lane | 1,250,000 | 6,249,812 | — | 3,096,125 | 10,620,815 |
| 10 | Encompass Health Corp. | 2025 | Mark Tarr | 1,100,000 | 5,285,381 | 1,165,376 | 2,581,525 | 10,297,258 |
| 11 | Option Care Health, Inc. | 2025 | John Rademacher | 1,000,000 | 6,500,050 | 0 | 1,665,000 | 9,266,330 |
| 12 | ABM Industries, Inc. | 2025 | Scott Salmirs | 1,025,000 | 6,449,997 | 0 | 1,622,188 | 9,111,185 |
| 13 | Rollins, Inc. | 2025 | Jerry Gahlhoff, Jr. | 1,100,000 | 6,128,643 | 0 | 1,683,000 | 8,966,870 |
| 14 | Surgery Partners, Inc. | 2025 | J. Eric Evans | 1,050,000 | 5,000,000 | 0 | 0 | 6,083,862 |
| 15 | Clean Harbors, Inc. | 2025 | Eric Gerstenberg | 1,000,000 | 3,197,110 | 0 | 1,719,000 | 5,929,422 |
| 16 | Brookdale Senior Living, Inc. | 2025 | Nikolas Stengle | 229,310 | 4,283,968 | 0 | 403,571 | 5,307,655 |
| 17 | Healthcare Services Group, Inc. | 2025 | Theodore Wahl | 1,005,108 | 2,475,457 | 818,544 | 330,851 | 4,725,723 |
| 18 | Select Medical Holdings Corp. | 2025 | Thomas Mullin | 618,000 | 1,425,000 | 0 | 939,360 | 3,042,527 |
| 19 | National Healthcare Corp. | 2025 | Stephen Flatt | 577,000 | 505,215 | 300,481 | 1,280,000 | 2,685,370 |
| 20 | Team, Inc. | 2025 | Keith Tucker | 750,000 | 0 | 0 | 495,119 | 1,265,655 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Chemed Corp | not disclosed | not disclosed | Yes — 3-Year Relative Total Shareholder Return (TSR) | Compensation Strategies, Inc. |
| ABM Industries, Inc. | 105% | PSU 60 · RSU 40 | No | Pay Governance |
| Acadia Healthcare Co., Inc. | not disclosed | PSU 60 · RSU 40 | Yes — Relative TSR compared to the TSR peer group | Ferguson Partners |
| Addus Homecare Corp. | not disclosed | Restricted Stock 100 | not disclosed | FW Cook |
| AMN Healthcare Services, Inc. | 87% | not disclosed | Yes — Relative TSR | FW Cook |
| Brookdale Senior Living, Inc. | 125.7% | not disclosed | No | F.W. Cook & Co., Inc. |
| Clean Harbors, Inc. | not disclosed | not disclosed | No | Meridian Compensation Partners |
| Comfort Systems USA, Inc. | 200% | PSU 50 · RSU 50 | No | Willis Towers Watson |
| Encompass Health Corp. | 173.8% | PSU 60 · RSU 20 · Options 20 | No | Pay Governance |
| Healthcare Services Group, Inc. | not disclosed | not disclosed | Yes — relative Total Shareholder Return (TSR) | not disclosed |
| National Healthcare Corp. | not disclosed | not disclosed | not disclosed | false |
| Option Care Health, Inc. | 111% | PSU 60 · RSU 40 | No | Pearl Meyer |
| Pediatrix Medical Group | 180% | RSU 50 · PSU 50 | No | Semler Brossy Consulting Group |
| RadNet, Inc. | not disclosed | RSU 100 | No | Pearl Meyer |
| Rollins, Inc. | 102% | RSU 72 · PSU 28 | Yes — TSR | Mercer |
| Select Medical Holdings Corp. | 190% | RSU 100 | not disclosed | not disclosed |
| Surgery Partners, Inc. | not disclosed | PSU 60 · Restricted Stock 40 | No | Frederic W. Cook & Co., Inc. (FW Cook) |
| Team, Inc. | not disclosed | PSU 70 · RSU 30 | No | Willis Towers Watson (WTW) |
| Tetra Tech, Inc. | not disclosed | PSU 60 · RSU 40 | Yes — Relative TSR | Meridian Compensation Partners |
| The Ensign Group, Inc. | not disclosed | not disclosed | not disclosed | Willis Towers Watson |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-18 | 4,383,683 | 6,926,656 | 12,363 | 38.76% | Failed |
| 2025 | 2025-05-19 | 11,039,768 | 1,656,237 | 320,853 | 86.95% | Passed |
| 2024 | 2024-05-20 | 11,126,353 | 2,312,361 | 14,433 | 82.79% | Passed |
| 2023 | 2023-05-15 | 10,359,330 | 3,020,668 | 35,717 | 77.42% | Passed |
| 2022 | 2022-05-16 | 11,807,439 | 1,372,825 | 14,095 | 89.58% | Passed |
| 2021 | 2021-05-17 | 13,373,906 | 673,428 | 27,195 | 95.21% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-05-18 | 38.76%a |
| 2025 | 2025-05-19 | 86.95%b |
| 2024 | 2024-05-20 | 82.79%c |
a. Approved under the standard stated in the filing — “ 3 VOTE REQUI REME NTS Proposal Vote Required Voting Options Effect of Abstentions Broker Discretionary Voting Allowed? Effect of Broker Non-Votes Recommended Vote Election of Directors (Proposal 1) Votes cast for exceed votes cast against FOR, AGAINST or ABSTAIN No effect, not treated as a "vote cast" No No effect, not treated as a "vote cast" FOR Ratification of Auditor Appointment (Proposal 2) Majority of shares with voting power present in person or represented by proxy FOR, AGAINST or ABSTAIN Treated as a vote AGAINST the proposal Yes Not applicable FOR Non-Binding Advisory Vote on Executive Compensation (Say On Pay) (Proposal 3) Majority of shares with voting power present in person or represented by proxy FOR, AGAINST or ABSTAIN Treated as a vote AGAINST the proposal No No effect - not entitled to vote FOR HOW TO VOTE;”.
b. Approved under the standard stated in the filing — “ 3 VOTE REQUI REME NTS Proposal Vote Required Voting Options Effect of Abstentions Broker Discretionary Voting Allowed? Effect of Broker Non-Votes Recommended Vote Election of Directors (Proposal 1) Votes cast for exceed votes cast against FOR, AGAINST or ABSTAIN No effect, not treated as a "vote cast" No No effect, not treated as a "vote cast" FOR Approval and Adoption of 2025 Stock Incentive Plan (Proposal 2) Majority of shares with voting power present in person or represented by proxy FOR, AGAINST or ABSTAIN Treated as a vote AGAINST the proposal No No effect - not entitled to vote FOR Ratification of Auditor Appointment (Proposal 3) Majority of shares with voting power present in person or represented by proxy FOR, AGAINST or ABSTAIN Treated as a vote AGAINST the proposal Yes Not applicable FOR Non-Binding Advisory Vote on Executive Compensation (Say On Pay) (Proposal 4) Majority of shares with voting power present in person or represented by proxy FOR, AGAINST or ABSTAIN Treated as a vote AGAINST the proposal No No effect - not entitled to vote FOR Stockholder Proposal to Reduce Voting Power Threshold for Calling a Special Meeting to 10% (Proposal 5) Majority of shares with voting power present in person or represented by proxy FOR, AGAINST or ABSTAIN Treated as a vote AGAINST the proposal No No effect - not entitled to vote AGAINST HOW TO VOTE;”.
c. Approved under the standard stated in the filing — “ 3 VOTE REQUI REME NTS Proposal Vote Required Voting Options Effect of Abstentions Broker Discretionary Voting Allowed? Effect of Broker Non-Votes Recommended Vote Election of Directors (Proposal 1) Votes cast for exceed votes cast against FOR, AGAINST or ABSTAIN No effect, not treated as a "vote cast" No No effect, not treated as a "vote cast" FOR Ratification of Auditor Appointment (Proposal 2) Majority of shares with voting power present in person or represented by proxy FOR, AGAINST or ABSTAIN Treated as a vote AGAINST the proposal Yes Not applicable FOR Non-Binding Advisory Vote on Executive Compensation (Say On Pay) (Proposal 3) Majority of shares with voting power present in person or represented by proxy FOR, AGAINST or ABSTAIN Treated as a vote AGAINST the proposal No No effect - not entitled to vote FOR Stockholder Proposal Requesting Stockholder Opportunity to Vote on Excessive Golden Parachutes (Proposal 4) Majority of shares with voting power present in person or represented by proxy FOR, AGAINST or ABSTAIN Treated as a vote AGAINST the proposal No No effect - not entitled to vote AGAINST HOW TO VOTE;”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 209 : 1 |
|---|---|
| CEO total compensation | $12,904,720 |
| Median employee compensation | $61,813 |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Kevin McNamara | Director | 2026-05-01 | D | 2,000 | $421 | $842,260 | Common | Form 4 ↗ |
| Patrick P. Grace | Director | 2026-05-08 | D | 60 | 426 | 25,547 | Common | Form 4 ↗ |
| George J. Walsh III | Director | 2026-05-18 | A | 386 | 441 | 170,137 | Common | Form 4 ↗ |
| Eileen P. McCarthy | Director | 2026-05-18 | A | 386 | 441 | 170,137 | Common | Form 4 ↗ |
| Andrea R. Lindell | Director | 2026-05-18 | A | 386 | 441 | 170,137 | Common | Form 4 ↗ |
| Christopher J. Heaney | Director | 2026-05-18 | A | 386 | 441 | 170,137 | Common | Form 4 ↗ |
| Ron DeLyons | Director | 2026-05-18 | A | 386 | 441 | 170,137 | Common | Form 4 ↗ |
| Patrick P. Grace | Director | 2026-05-18 | A | 386 | 441 | 170,137 | Common | Form 4 ↗ |
| John M. Mount Jr | Director | 2026-05-18 | A | 386 | 441 | 170,137 | Common | Form 4 ↗ |
| George J. Walsh III | Director | 2026-05-29 | D | 500 | 438 | 218,915 | Common | Form 4 ↗ |
| Andrea R. Lindell | Director | 2026-06-09 | D | 1,347 | 447 | 602,554 | Common | Form 4 ↗ |
| Patrick P. Grace | Director | 2026-07-31 | D | 190 | 532 | 101,080 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
Sources (85 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Kevin McNamara. DEF 14A, filed 2026-04-09. Section “Narrative to Summary Compensation Table and Grants of Plan-Based Awards Table” · page 28. As printed: 12,904,720. View filing ↗
- Section 01, Nicholas Westfall. DEF 14A, filed 2026-04-09. Section “Narrative to Summary Compensation Table and Grants of Plan-Based Awards Table” · page 28. As printed: 4,294,862. View filing ↗
- Section 01, Michael Witzeman. DEF 14A, filed 2026-04-09. Section “Narrative to Summary Compensation Table and Grants of Plan-Based Awards Table” · page 28. As printed: 3,714,742. View filing ↗
- Section 01, Spencer Lee. DEF 14A, filed 2026-04-09. Section “Narrative to Summary Compensation Table and Grants of Plan-Based Awards Table” · page 28. As printed: 3,208,764. View filing ↗
- Section 01, Joel Wherley. DEF 14A, filed 2026-04-09. Section “Narrative to Summary Compensation Table and Grants of Plan-Based Awards Table” · page 28. As printed: 3,049,989. View filing ↗
- Section 01, Brian Judkins. DEF 14A, filed 2026-04-09. Section “Narrative to Summary Compensation Table and Grants of Plan-Based Awards Table” · page 28. As printed: 2,658,997. View filing ↗
- Section 03, Brian Judkins RSU. DEF 14A, filed 2026-04-09. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Kevin McNamara RSU. DEF 14A, filed 2026-04-09. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Kevin McNamara OPTION. DEF 14A, filed 2026-04-09. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Brian Judkins OPTION. DEF 14A, filed 2026-04-09. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Michael Witzeman RSU. DEF 14A, filed 2026-04-09. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Joel Wherley RSU. DEF 14A, filed 2026-04-09. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Joel Wherley RSU. DEF 14A, filed 2026-04-09. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Joel Wherley OPTION. DEF 14A, filed 2026-04-09. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Nicholas Westfall RSU. DEF 14A, filed 2026-04-06. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Kevin McNamara RSU. DEF 14A, filed 2026-04-09. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Michael Witzeman RSU. DEF 14A, filed 2026-04-09. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Michael Witzeman OPTION. DEF 14A, filed 2026-04-09. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Spencer Lee RSU. DEF 14A, filed 2026-04-09. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Spencer Lee RSU. DEF 14A, filed 2026-04-09. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Spencer Lee OPTION. DEF 14A, filed 2026-04-09. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Brian Judkins RSU. DEF 14A, filed 2026-04-09. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Nicholas Westfall RSU. DEF 14A, filed 2026-04-06. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-04-06. Section “CEO Pay Ratio”. As printed: 209 : 1. View filing ↗
- Section 08, George J. Walsh III. DEF 14A, filed 2026-04-09. Section “Director Compensation”. As printed: 495,027. View filing ↗
- Section 08, Patrick P. Grace. DEF 14A, filed 2026-04-09. Section “Director Compensation”. As printed: 313,894. View filing ↗
- Section 08, Christopher J. Heaney. DEF 14A, filed 2026-04-09. Section “Director Compensation”. As printed: 286,394. View filing ↗
- Section 08, John M. Mount Jr. DEF 14A, filed 2026-04-09. Section “Director Compensation”. As printed: 281,894. View filing ↗
- Section 08, Ron DeLyons. DEF 14A, filed 2026-04-09. Section “Director Compensation”. As printed: 281,894. View filing ↗
- Section 08, Eileen P. McCarthy. DEF 14A, filed 2026-04-09. Section “Director Compensation”. As printed: 275,394. View filing ↗
- Section 08, Andrea R. Lindell. DEF 14A, filed 2026-04-09. Section “Director Compensation”. As printed: 275,394. View filing ↗
- Section 08, Thomas P. Rice. DEF 14A, filed 2026-04-09. Section “Director Compensation”. As printed: 52,583. View filing ↗
- Section 02, Kevin McNamara 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick P. Grace 2026-05-08. Form 4, filed 2026-05-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, George J. Walsh III 2026-05-18. Form 4, filed 2026-05-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Eileen P. McCarthy 2026-05-18. Form 4, filed 2026-05-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrea R. Lindell 2026-05-18. Form 4, filed 2026-05-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher J. Heaney 2026-05-18. Form 4, filed 2026-05-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ron DeLyons 2026-05-18. Form 4, filed 2026-05-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick P. Grace 2026-05-18. Form 4, filed 2026-05-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John M. Mount Jr 2026-05-18. Form 4, filed 2026-05-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, George J. Walsh III 2026-05-29. Form 4, filed 2026-05-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrea R. Lindell 2026-06-09. Form 4, filed 2026-06-10. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick P. Grace 2026-07-31. Form 4, filed 2026-08-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-05-19. Item 5.07 · say-on-pay result. As reported: 38.76% (votes for as printed: 4,383,683). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-05-20. Item 5.07 · say-on-pay result. As reported: 86.95% (votes for as printed: 11,039,768). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-05-21. Item 5.07 · say-on-pay result. As reported: 82.79% (votes for as printed: 11,126,353). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 1,038,583 + equity 1,169,258 + all other 54,633 = 2,262,474, summed across the director compensation table rows.
- Pediatrix Medical Group, Section 10b CEO total. DEF 14A, filed 2026-03-27. CEO total compensation as printed in Pediatrix Medical Group's own proxy. As printed: 14,140,217. View filing ↗
- The Ensign Group, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in The Ensign Group, Inc.'s own proxy. As printed: 13,804,700. View filing ↗
- Chemed Corp (subject), Section 10b CEO total. DEF 14A, filed 2026-04-09. CEO total compensation as printed in Chemed Corp's own proxy. As printed: 12,904,720. View filing ↗
- Acadia Healthcare Co., Inc., Section 10b CEO total. DEF 14A, filed 2026-04-07. CEO total compensation as printed in Acadia Healthcare Co., Inc.'s own proxy. As printed: 12,855,422. View filing ↗
- Addus Homecare Corp., Section 10b CEO total. DEF 14A, filed 2026-04-23. CEO total compensation as printed in Addus Homecare Corp.'s own proxy. As printed: 12,190,449. View filing ↗
- RadNet, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-20. CEO total compensation as printed in RadNet, Inc.'s own proxy. As printed: 12,087,934. View filing ↗
- Tetra Tech, Inc., Section 10b CEO total. DEF 14A, filed 2026-01-09. CEO total compensation as printed in Tetra Tech, Inc.'s own proxy. As printed: 11,622,399. View filing ↗
- AMN Healthcare Services, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-18. CEO total compensation as printed in AMN Healthcare Services, Inc.'s own proxy. As printed: 10,669,780. View filing ↗
- Comfort Systems USA, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-09. CEO total compensation as printed in Comfort Systems USA, Inc.'s own proxy. As printed: 10,620,815. View filing ↗
- Encompass Health Corp., Section 10b CEO total. DEF 14A, filed 2026-04-07. CEO total compensation as printed in Encompass Health Corp.'s own proxy. As printed: 10,297,258. View filing ↗
- Option Care Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-08. CEO total compensation as printed in Option Care Health, Inc.'s own proxy. As printed: 9,266,330. View filing ↗
- ABM Industries, Inc., Section 10b CEO total. DEF 14A, filed 2026-02-13. CEO total compensation as printed in ABM Industries, Inc.'s own proxy. As printed: 9,111,185. View filing ↗
- Rollins, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-17. CEO total compensation as printed in Rollins, Inc.'s own proxy. As printed: 8,966,870. View filing ↗
- Surgery Partners, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-23. CEO total compensation as printed in Surgery Partners, Inc.'s own proxy. As printed: 6,083,862. View filing ↗
- Clean Harbors, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-10. CEO total compensation as printed in Clean Harbors, Inc.'s own proxy. As printed: 5,929,422. View filing ↗
- Brookdale Senior Living, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-30. CEO total compensation as printed in Brookdale Senior Living, Inc.'s own proxy. As printed: 5,307,655. View filing ↗
- Healthcare Services Group, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-15. CEO total compensation as printed in Healthcare Services Group, Inc.'s own proxy. As printed: 4,725,723. View filing ↗
- Select Medical Holdings Corp., Section 10b CEO total. DEF 14A, filed 2026-03-04. CEO total compensation as printed in Select Medical Holdings Corp.'s own proxy. As printed: 3,042,527. View filing ↗
- National Healthcare Corp., Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in National Healthcare Corp.'s own proxy. As printed: 2,685,370. View filing ↗
- Team, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-28. CEO total compensation as printed in Team, Inc.'s own proxy. As printed: 1,265,655. View filing ↗
- Section 10a, Healthcare Services Group, Inc. reciprocity. DEF 14A. Healthcare Services Group, Inc. names Chemed Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Addus Homecare Corp. reciprocity. DEF 14A. Addus Homecare Corp. names Chemed Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Acadia Healthcare Co., Inc. reciprocity. DEF 14A. Acadia Healthcare Co., Inc.'s most recent proxy was read; its disclosed peer group does not include Chemed Corp. View filing ↗
- Section 10a, Brookdale Senior Living, Inc. reciprocity. DEF 14A. Brookdale Senior Living, Inc. names Chemed Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Rollins, Inc. reciprocity. DEF 14A. Rollins, Inc.'s most recent proxy was read; its disclosed peer group does not include Chemed Corp. View filing ↗
- Section 10a, Surgery Partners, Inc. reciprocity. DEF 14A. Surgery Partners, Inc. names Chemed Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Tetra Tech, Inc. reciprocity. DEF 14A. Tetra Tech, Inc.'s most recent proxy was read; its disclosed peer group does not include Chemed Corp. View filing ↗
- Section 10a, ABM Industries, Inc. reciprocity. DEF 14A. ABM Industries, Inc.'s most recent proxy was read; its disclosed peer group does not include Chemed Corp. View filing ↗
- Section 10a, Option Care Health, Inc. reciprocity. DEF 14A. Option Care Health, Inc. names Chemed Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, RadNet, Inc. reciprocity. DEF 14A. RadNet, Inc. names Chemed Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, AMN Healthcare Services, Inc. reciprocity. DEF 14A. AMN Healthcare Services, Inc.'s most recent proxy was read; its disclosed peer group does not include Chemed Corp. View filing ↗
- Section 10a, Clean Harbors, Inc. reciprocity. DEF 14A. Clean Harbors, Inc. names Chemed Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Encompass Health Corp. reciprocity. DEF 14A. Encompass Health Corp. names Chemed Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Team, Inc. reciprocity. DEF 14A. Team, Inc.'s most recent proxy was read; its disclosed peer group does not include Chemed Corp. View filing ↗
- Section 10a, The Ensign Group, Inc. reciprocity. DEF 14A. The Ensign Group, Inc.'s most recent proxy was read; its disclosed peer group does not include Chemed Corp. View filing ↗